Abstract
Sex differences in heart failure development following myocardial infarction (MI) are not fully understood. We hypothesized that differential MI signaling could explain variations in outcomes. Analysis of the mouse heart attack research tool 1.0 (422 mice; young = 5.4 ± 0.1; old = 23.3 ± 0.1 months of age) was used to dissect MI signaling pathways, which was validated in a new cohort of mice (4.8 ± 0.2 months of age); and substantiated in humans. Plasma collected at visit 2 from the MI subset of the Jackson Heart Study (JHS; a community-based study consisting of middle aged and older adults of African ancestry) underwent glycoproteomics grouped by outcome: (1) heart failure hospitalization after visit 2 (n = 3 men/12 women) and (2) without hospitalization through 2012 (n = 24 men/21 women). Compared to young male mice, the infarct region of young females had fewer, but more efficient tissue clearing neutrophils with reduced pro-inflammatory gene expression. Apolipoprotein (Apo) F, which acts upstream of the liver X receptors/retinoid X receptor (LXR/RXR) pathway, was elevated in the day 7 infarcts of old mice compared to young controls and was increased in both men and women with heart failure. In vitro, Apo F stimulated CD36 and peroxisome proliferator-activated receptor (PPAR)γ activation in male neutrophils to turn off NF-κB activation and stimulate LXR/RXR signaling to initiate resolution. Female neutrophils were desensitized to Apo F and instead relied on thrombospondin-1 stimulation of CD36 to upregulate AMP-activated protein kinase, resulting in an overall better wound healing strategy. With age, female mice were desensitized to LXR/RXR signaling, resulting in enhanced interleukin-6 activation, a finding replicated in the JHS community cohort. This is the first report to uncover sex differences in post-MI neutrophil signaling that yielded better outcomes in young females and worse outcomes with age.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The average age for a first myocardial infarction (MI) is 65 years for men and 72 years for women [4]. Differences between men and women in long-term prognosis after MI have been attributed to age, clinical presentation, and treatment utilization [7, 60]. Following MI, the left ventricle (LV) undergoes a wound healing response that involves necrotic tissue removal and deposition of a replacement scar composed of extracellular matrix proteins. Immune cells polarize to a pro-inflammatory state and release enzymes such as matrix metalloproteinases (MMPs) and reactive oxygen species (ROS) that catalyze necrotic tissue removal [16, 18, 48]. Infiltrating leukocytes also secrete cytokines and growth factors such as pro-inflammatory interleukin (IL)1β and reparative transforming growth factor β [18, 81].
Women have a more temperate response to inflammatory stimuli; for example, in sepsis and atherosclerosis, they have lower pro-inflammatory leukocyte-mediated inflammation and accelerated resolution of inflammation compared to men [66, 71]. Whether and to what extent sex differences exist in the post-MI inflammatory and wound healing response has not been previously examined.
The goal of this study, accordingly, was to assess sex differences in post-MI responses using a combination of experimental MI in mice and human post-MI proteomic data from a well-characterized longitudinal cardiovascular study of an African American population: the Jackson Heart Study. We hypothesized that differential signaling activation following MI could explain sex differences in cardiac remodeling in mice and humans. We used convergent methods to compare alterations in LV gene with plasma and LV protein and a cross-translational approach to compare results in mice and humans, and performed cell phenotyping and physiology analyses to evaluate common and contrasting signaling responses.
Materials and methods (detailed methods in supplemental materials)
Analysis of the mouse heart attack research tool (mHART) 1.0 database [17]
The mHART database consists of data collected from projects published since 2007 [17]. The article describing the development of the database included a preliminary example of dilation responses. Here, we expand the original observation to identify molecular and cellular mechanisms that explain sex differences in MI outcomes. Data were collected for inclusion in the database from projects published in our lab for male and female mice ranging from 3 to 36 months of age [10, 13, 14, 31, 32, 50, 52, 53, 81, 86,87,88]. For this study, we analyzed data from 422 male and female C56BL/6 J wild-type (WT) mice (Online Table 1 and Fig. 1). At autopsy, cardiac rupture in non-surviving mice was confirmed by the presence of coagulated blood in the thoracic cavity or observation of the rupture site on the LV.
Sample selection
The database was accessed on April 15, 2017. Of 2095 mice downloaded, 759 were WT post-MI mice. Of 759 mice, 422 had echocardiography and plasma or gene RT-PCR data at days 0 (n = 161; 70 F and 91 M), 1 (n = 38; 15 F and 23 M), 3 (n = 46; 18 F and 28 M), and 7 (n = 95; 47 F and 48 M) post-MI. Both MI surgeries and echocardiography were performed according to established guidelines [49, 51].
Immunoblotting of banked tissue
Immunoblotting was performed to evaluate Apo F and CD36 in the LV infarct of young and old male and female hearts (n = 5/sex/day post-MI; Online Fig. 1a).
Neutrophil cell isolation
To explore new hypotheses generated by the database analysis, WT mice (3–6 months-old) were used in accordance with the Guide for the Care and Use of Laboratory Animals (Eighth edition) in a protocol approved by our IACUC. Mice were subjected to permanent occlusion of the left anterior descending coronary artery [32].
Neutrophil phenotyping
Neutrophils were isolated from the infarct at day 1 post-MI (n ≥ 8 mice/group) [54]. RNA array experiments were performed according to the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines with one exception; hypoxanthine guanine phosphoribosyl transferase 1 (Hprt1) was the only reference gene used, as GusB, Hsp90ab1, Actb, and Gapdh have all been shown to change after MI [32]. Immunoblotting results for isolated neutrophils are shown in Online Fig. 1b.
In vitro neutrophil stimulation
To establish causality, neutrophils were isolated from the bone marrow of no MI naive mice [54]. Cells (5 × 105 condition) were stimulated with Apo F with or without CD36 blocking antibody (CD36i) for 15 min at 37 °C.
Tissue clearance capacity
Ex vivo neutrophils and macrophages isolated from the day 1 LV infarct were plated in duplicate (1.0 × 105 cells/well) onto gelatin coated 48-well plates. In vitro neutrophils were stimulated with Apo F or 50 µL of the secretome (10% final volume). Tissue clearance was calculated by normalizing absorbance of the negative controls (wells without cells) using the following formula: 1-[(sample Abs/(negative control Abs)].
Multiplex cellular imaging
Opal multiplex immunohistochemistry was performed on isolated neutrophils, using antibodies specific for nuclear factor (NF)κB-p65 or peroxisome proliferator-activated receptor (PPAR)γ, with DAPI as a nuclear counterstain and according to established guidelines for antibody use [5]. Images were acquired on the Mantra™ Quantitative Pathology Imaging microscope. The number of cells with nuclear staining were counted and calculated as percentage of total cell numbers.
Jackson Heart Study data
The Jackson Heart Study is a community-based cohort study that consists of 5306 African American participants between the ages of 21 and 94 years [83]. Incident heart failure events were formally adjudicated by Jackson Heart Study from January 1, 2005 to December 31, 2012. Participants who did not have an MI before visit 2, had heart failure at or before visit 2, were diagnosed with MI after 2008, or did not have plasma collected at visit 2 were excluded, leaving a final sample size of 60 participants, which were analyzed using glycoproteomics as described previously [15, 19, 76, 77]. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE [80] partner repository with the dataset identifier PXD009870.
Statistics
Animal and human datasets underwent functional analysis using Ingenuity Pathway Analysis (IPA; QIAGEN Redwood City; www.qiagen.com/ingenuity). Multiple-testing corrected p values were calculated in IPA using the Benjamini–Hochberg method. Fold change was calculated for each sex by normalizing MI + HF data to the respective MI only samples for the clinical samples. Mouse data were normalized to their respective day 0 dataset. This allowed us to focus on changes that predict heart failure and LV remodeling. The most statistically significant canonical pathways identified are ranked according to p value. The ratio given is the number of pathway proteins identified in the glycoproteomics dataset divided by the total number of proteins in that pathway, which reflects percentage of pathway coverage. The Z score was calculated based on expected relationship direction and observed gene expression differences in MI vs MI + HF for each sex.
Causal and upstream network analyses were employed to identify molecules upstream of the measured genes and proteins in the dataset that explained the observed expression changes. IPA statistical analysis scored regulators whose network connections were highly unlikely to occur in a random model. A cut off of the overlap p value measuring enrichment of network-regulated genes and the activation Z score was used to identify regulating molecules and to predict regulator activation state. Heat maps and volcano plots were constructed using a statistical program available in the Metaboanalyst 3.0 package (www.metaboanalyst.ca/) [82, 85].
All statistical analyses were performed by investigators blinded to groups. Animal studies are presented as mean ± SEM and community-based cohort data as mean ± SD. Two group comparisons were analyzed by Student’s t test. Multiple group comparisons were analyzed using one-way ANOVA, followed by the Student–Newman-Keuls when the Bartlett’s variation test was passed, or the nonparametric Kruskal–Wallis test, followed by Dunn post hoc test when the Bartlett’s variation test did not pass. Statistical significance was set at p < 0.05.
Study approval
This study complies with the Declaration of Helsinki [84]. All animal procedures were approved by the Institutional Animal Care and Use Committee at the University of Mississippi Medical Center in accordance with the Guide for the Care and Use of Laboratory Animals and followed the ARRIVE guidelines [37]. The Jackson Heart Study was approved by the institutional review boards of the University of Mississippi Medical Center, Jackson State University, and Tougaloo College. All participants provided written informed consent. This study was approved as IRB #2014-0274.
Results
Post-MI outcome was improved and inflammation attenuated in young female mice
At day 7 post-MI, young female mice showed improved survival (74 vs 40% for males; p = 0.003), less rupture (11 vs. 46% for males, p = 0.041) and attenuated LV dilation, even when normalized to LV mass index (Fig. 2a, b). Infarct areas were similar between sexes (Online Table 2), indicating observed changes were not due to differences in initial injury stimulus.
Inflammation was robustly upregulated in males compared to no MI controls, and this induction was blunted in female mice (Fig. 2c–f). The main drivers of sex-dependent LV remodeling regulation at day 1 were IL6Rα, Cxcr3, IL13, and IL1r1 (Fig. 2e; all > twofold lower and p < 0.05 in females compared to males). In addition to these 4 genes, Cxcl4 and tissue inhibitor of matrix metalloproteinase (TIMP)-3 were lower in young female mice compared to males (both p < 0.05). At day 7, TIMP-3, ATP binding cassette subfamily F member-1, Ccl25, Cxcl12, integrin-a3, and thrombospondin (TSP)-1 and -3 were lower in female mice compared to male mice (Fig. 2f, all p < 0.05). Post-MI neutrophil infiltration was robust by day 1 and returned to baseline levels by day 7 in both male and female young mice (Fig. 3a and Online Fig. 2). While the time course was similar, males had higher neutrophil numbers at day 3 compared to females, consistent with the higher pro-inflammatory status and previous studies showing more cardiac rupture and neutrophil infiltration in male mice [9].
While post-MI plasma IL6 concentrations increased at day 1 and peaked at day 3 in both sexes (Fig. 3b), females had reduced IL6 receptor (IL6R) gene and protein expression in the infarct at day 1 compared to males (p < 0.05; Fig. 2e and Online Fig. 1a). IL6R gene expression at day 3 post-MI correlated with neutrophil numbers in female mice (r = 0.85; p = 0.03) but not male mice (r = 0.67; p = 0.33), consistent with lower neutrophil numbers in females in response to IL6 chemoattraction [22, 40, 70]. In young female mice, plasma IL6 protein returned to baseline by day 7 post-MI; whereas IL6 resolution was delayed and remained elevated at day 7 in males. Female mice were more sensitive to sustained IL6, as increased plasma IL6 at day 7 correlated with increased end diastolic dimension in females, but not males (Fig. 3c). Macrophage (Mac-3 +) cell numbers were similar in male and female mice, both for timing and magnitude of response (Fig. 3d). Vessel formation in the infarct zone, denoted by Griffonia (Bandeiraea) Simplicifolia Lectin I (GSL)-lectin + cells, occurred earlier in male mice, as vessel numbers peaked at day 5 and were higher compared to female mice (Fig. 3e).
Canonical pathway analysis of 165 inflammatory and extracellular matrix genes and 56 plasma proteins measured over the day 0–7 post-MI time course identified 16 pathways associated with LV remodeling in both males and females (Fig. 4). Two pathways (IL-8 and chemokine) were similar in direction of change and magnitude between young males and females, designating shared common regulation. The other 14 pathways followed one of the five distinct patterns: (1) same direction with lower magnitude of change in females (liver X receptors/retinoid X receptor (LXR/RXR), peroxisome proliferator-activated receptor (PPAR), and triggering receptor expressed on myeloid cells (TREM)-1); (2) same direction with slower increase in females (integrin, acute phase response, NF-ĸB, high-mobility group protein 1, Th2); (3) same direction with earlier resolution in females (IL6, CD40, Th1); (4) increase in females only (TSP); and (5) opposite direction of magnitude [nitric oxide (NO) and reactive oxygen species (ROS) production and toll-like receptor (TLR) activation]. Combined, these results indicate males had a more robust response to ischemia induced cardiac injury resulting in poor survival and adverse remodeling compared to females.
Post-MI sex differences were dependent on neutrophil signaling
Previously, we showed that neutrophils can polarize to a pro-inflammatory (N1) or anti-inflammatory (N2) phenotype [54]. Out of six N1 markers, day 1 neutrophils from females had elevated Ccl5 gene and reduced Ccl5 protein expression compared to neutrophils isolated from the infarct of males (Fig. 5a). The divergence in gene and protein expression indicates that females may have a feedback loop to signal induction of gene expression due to reduced protein. IL6, IL12a, and Tnfα gene and protein were lower per cell in neutrophils isolated from female mice at day 1 compared to male neutrophils (Fig. 5b; p < 0.05 and Online Fig. 1b). IL1β was not different between sexes. Out of the four N2 gene markers assayed, Arg1 and CD206 were higher, Ym1 was lower, and Tgfβ was not different in day 1 female neutrophils (Fig. 5c). At the protein level, only CD206 was elevated in neutrophils isolated at day 1 post-MI from female mice. These results indicate neutrophils from females show reduced N1 and greater N2 polarization.
By tissue clearance assay, neutrophils from the infarct of females showed greater tissue clearance capacity per cell compared to neutrophils isolated from males (Fig. 5d) When we assessed the tissue clearance capacity of macrophages isolated from the day 1 infarcts, no significant difference was found between sexes (p = 0.52). To assess if neutrophil mediated-tissue clearance was due to elevated MMPs, MMP-8 and -9 gene expression was evaluated in day 1 neutrophils (Fig. 5e). Neither MMP-8 nor -9 were different between sexes, indicating female neutrophils are more efficient at removal of necrotic tissue without inducing excessive extracellular matrix degradation. Overall, post-MI female neutrophils displayed lower inflammatory markers, which may result in less overall damage to the myocardium.
With aging, female mice lose the ability to activate LXR/RXR signaling
Women show greater protection from cardiovascular disease until menopause. Mice reach the endocrine equivalent of human perimenopause by 9 months of age [23, 26, 56]. To dissect post-MI age vs. hormonal effects, we compared young (3–9 month-old) and old (11–36 month-old) mice within the mHART 1.0 database. Sparse partial least squares discriminant analysis revealed day 7 post-MI young females clustered with day 7 post-MI young males, whereas day 7 post-MI old females and males clustered as two distinct groups (Fig. 6a) signifying male and female differences became more prominent with age.
With age, activation of a number of pathways were amplified in females compared to their young female counterparts: IL6 (Z score = 1.0 for young, 3.5 for old), acute phase response (Z score = 1.6 for young, 3.9 for old), IL8 (Z score = 0.8 for young, 3.1 for old), high-mobility group protein 1 (Z score = 2.5 for young, 3.7 for old), chemokine (Z score = 0.7 for young, 2.1 for old), and production of NOS and ROS (Z score = 0.8 for young, 1.6 for old; Fig. 6b). These results revealed a more robust response to ischemia in females with age. Compared to young females, two pathways downregulated in old females were LXR/RXR (Z score = − 0.7 for young, − 1.7 for old females) and PPAR (Z score = − 1.3 for young, − 3.2 for old females), signifying age-related desensitization. Male mice had no change in any of these pathways with age. Both old male and female mice had exacerbated toll-like receptor and integrin signaling and blunted CD40, TREM, and Th1 signaling responses to MI compared to their young counterparts. In contrast, MI activation of Th2 and NF-κB signaling were amplified in females and blunted in males with age.
IL6 is a hallmark trigger for the acute-phase response and is inhibited by LXR/RXR activation [3, 41]. To determine if age-induced deactivation of LXR/RXR signaling in females explained the increase in IL6 signaling, infarct expression of IL6 signal transduction (IL6st) and IL6 receptor alpha (IL6ra) genes at day 7 post-MI were evaluated. MI-induced increases in IL6st and IL6ra were exacerbated with age in females, and IL6st was elevated in old females compared to old males (Fig. 6c). IL6st correlated with circulating fibrinogen, a marker for LXR/RXR activation, in old male but not old female mice (Fig. 6d), whereas IL6ra negatively correlated with fibrinogen in old female mice but not old males (Fig. 6e).
Apolipoprotein (Apo) F (lipid transfer inhibitory protein) regulates high-density lipoprotein metabolism and is an upstream activator of LXR/RXR signaling [45]. With age, apo F was similarly elevated in the day 7 infarcts of both sexes compared to young controls (Fig. 6f), indicating sex differences in signaling occur downstream of apo F. CD36 acts downstream of apo F and is known to activate LXR/RXR. Old females had higher CD36 surface expression compared to young females (Fig. 6g) most likely as a compensation mechanism resulting from decreased LXR/RXR signaling with age.
Apo F stimulation of young male neutrophils activated LXR/RXR signaling through CD36 and PPARγ activation to turn off NF-kB activation, while neutrophils from young females were desensitized to apo F stimulation of PPARγ
Neutrophil stimulation with apo F in vitro increased tissue clearance capacity (Fig. 7a) in both sexes, with males showing a greater response to the same apo F dose. This was opposite to what was observed for the ex vivo MI stimulated neutrophils, where female cells had higher clearance rates. This may be due to differences in culture conditions, as the ex vivo tissue clearance measurements were performed using cells, while the in vitro tissue clearance assay was performed using only the secretome of stimulated cells. Using only the secretome for in vitro studies allowed the effects of secreted proteins vs. cellular mechanisms to be dissected. Phorbol 12-myristate 13-acetate (PMA) stimulation had no effect on tissue clearance (p = 0.17 for males and p = 0.08 for females), demonstrating tissue clearance was not regulated through protein kinase C [63, 72].
CD36 regulates tissue clearance through phagocytosis and MMP-9 secretion [19]. In male but not female neutrophils, apo F stimulated MMP-9 release from tertiary granules (Fig. 7b), and CD36i attenuated this response. Tissue clearance in female neutrophils, therefore, relied more on NO and ROS production than degranulation of proteolytic enzymes, as with age female mice had increased NO and ROS production.
Apo F stimulated the release of two anti-inflammatory N2 markers, Ym1 and the 75 kDa proteolytic fragment of CD206 (Fig. 7c, d) [19]. The loss of Ym1 explained the tissue clearance capacity in male neutrophils, as Ym1 has been linked to neutrophil-mediated degradation of N-glycans [28]. CD36i attenuated the apo F-induced Ym1 increase while having no effect on CD206 fragment production.
Apo F stimulation decreased IL6 secretion through CD36 in male, but not female neutrophils (Fig. 7e). Interestingly, CD36i induced Apo C-IV secretion by male and female neutrophils (Fig. 7f), with a greater effect in males. Apo C-IV is downstream of LXR/RXR activation and is a regulator of lipid transport and metabolism [6, 55]. When CD36 was blocked, apo C-IV no longer trafficked into the cell and accumulated in the secretome. Reduced LXR/RXR activation explained why females secreted lower levels of apo C-IV and had a compensatory CD36 increase with age.
To determine the mechanism of apo F regulation of neutrophil activation, nuclear localization of NF-κBp65 and PPARγ was assessed (Fig. 7g). Apo F activated PPARγ in male neutrophils (Fig. 7h), consistent with inhibition of IL6 and induction of Ym1 and CD206 [46, 64, 65]. This effect was attenuated by CD36i. Apo F stimulation did not activate PPARγ in female neutrophils; as a result, MMP-9, Ym1, CD206, and IL6 were not induced. TSP-1 signaling was upregulated in the infarct issue of post-MI females (Fig. 2), which may have resulted in upregulation of CD36, AMPK, and p38 MAPK signaling as compensatory mechanisms [12, 38, 69]. AMPK inhibits PPARγ activation [73], which links TSP-1 signaling to attenuation of LXR/RXR signaling.
While Apo F stimulation alone did not affect NF-κBp65 nuclear localization, CD36i induced NF-κBp65 translocation to the nucleus in both male and female neutrophils (Fig. 7i). As PPARγ is a negative regulator of NF-κB activation [1, 74], the decrease in PPARγ with CD36i would activate NF-κB. This is consistent with the tissue array results, which showed both males and females deactivated PPAR signaling early post-MI to activate NF-κB. Increased NF-κBp65 leads to an elevated pro-inflammatory response; thus activation of LXR/RXR signaling through apo F and PPARγ stimulated resolution of neutrophil-mediated inflammation in both sexes.
Loss of LXR/RXR signaling in women with MI correlated with increased risk of heart failure
To assess translational relevance of our findings in mice, we analyzed plasma samples from the Jackson Heart Study. Of the 60 individuals that met inclusion criteria, 15 experienced subsequent heart failure hospitalization after visit 2 (n = 3 men/12 women). This 25% post-MI heart failure development rate is consistent with incidence rates in past clinical reports [24, 29, 68, 79]. Women had a higher incidence of heart failure after visit 2 (447 events per 100 person-years) compared to men (56 events per 100 person-years). In addition, women who developed heart failure were older (73 ± 9 vs 58 ± 9 years) and had higher systolic blood pressure (146 ± 24 vs 108 ± 8 mmHg) and lower hemoglobin A1C levels (7.3 ± 2.0% vs 9.2 ± 0.9%) compared to men who progressed to heart failure (Online Table 3).
Glycoproteomic analysis identified 200 peptides (Online Table 4) belonging to 88 unique proteins. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD009870 (http://www.ebi.ac.uk/pride/archive/) [80]. By partial least squares discriminant analysis, participants with MI who later presented with adjudicated heart failure hospitalization showed a distinct separation of the sexes based on the lack of ellipse overlap (Fig. 8a). For participants with stable MI, there was a lack of sex effect based on the overlap of ellipses.
Glycoproteomic data from the heart failure group was normalized to respective sex MI only groups to identify early upregulation of glycoproteins that predict later heart failure development. By Ingenuity Pathway Analysis, pathways associated with MI response and not linked to heart failure development included the farnesoid X receptor (FXR)/RXR, atherosclerosis, clathrin-mediated endocytosis, and IL12 signaling and production pathways, all of which had a Z score of zero. Glycoproteins associated with heart failure mapped to the following pathways: LXR/RXR, acute phase response, complement system, coagulation system, production of NO and ROS pathways. Similar to the aged mice, pathways upregulated in men and downregulated in women included LXR/RXR (p = 1.36 × 10−29), acute phase response (p = 1.14 × 10−26), and coagulation (p = 9.09 × 10−10; Fig. 8b). The LXR/RXR and acute phase response pathways accounted for 22 of the 88 proteins (25%). Pathways in common to both men and women included complement system (downregulated) and production of NO and ROS (upregulated).
To assess if loss of LXR/RXR or acute phase signaling could facilitate heart failure development, we correlated the proteins identified in these pathways with QT interval measurements taken at visit 3. Longer QTc intervals associate with poor post-MI prognosis, including increased mortality and heart failure [2, 47]. Apo C-IV negatively correlated with longer QTc intervals in women, but not in men (Fig. 8c), while Apo F, fibrinogen, and orosomucoid 1 positively correlated with longer QTc intervals in men, but not women (Fig. 8d–f). Consistent with our in vitro neutrophil results, loss of LXR/RXR signaling in women decreased apo C-IV, increased QTc intervals, and facilitated the development of heart failure by failing to inhibit NF-κB and thus prolonging the inflammatory response. This is consistent with previous work by Mayr et al. who demonstrated a strong association between very low-density lipoprotein-associated apolipoproteins including C-II, C-III, and E with incident cardiovascular disease [62].
Interleukin 6 acted as a downstream regulator
Similar to mice, IL6 was a downstream regulator of sex differences during development of heart failure, as 28 of the 88 glycoproteins identified (32%) interact with IL6 (Fig. 9a). Of the 28 proteins within the network, apo C-IV, angiotensinogen, alpha-1-microglobulin, complement 4b-binding protein alpha, thrombin, serpinD1, serpinA5, and apo B were elevated in men who developed heart failure, but not in women. Women who went on to develop heart failure had significant upregulation of transthyretin. IL6 stimulates angiotensinogen, serum amyloid P, fibrinogen, and orosomucoid-1 and inhibits transthyretin [34, 41, 42] signifying men who developed heart failure had increased IL6 activity, whereas women with heart failure had decreased IL6 activity. Apo F, which acts upstream of the LXR/RXR pathway, [21] was increased in both men and women with heart failure. Fibrinogen and orosomucoid 1 were elevated and correlated with plasma IL6 receptor in women, but not men (Fig. 9b, c). These results revealed early plasma indicators of later heart failure development, with profiles distinguishing men and women.
Discussion
The goal of this study was to investigate post-MI sex differences in LV remodeling progression to heart failure. The most salient findings were: (1) in vivo, young female mice were more efficient than young males or old mice of either sex at resolving the inflammatory response through differences in neutrophil physiology; (2) in vitro, neutrophils from males stimulated with apo F activated the LXR/RXR pathway through CD36 and PPARγ activation to turn off NF-kB activation, while neutrophils from young females were desensitized to apo F stimulation of PPARγ and relied on TSP-1 stimulation of CD36 to upregulate AMPK and stimulate phagocytic potential; (3) with age, female mice were desensitized to LXR/RXR signaling, resulting in enhanced IL-6 activation; and (4) in humans, men and women remodeled using distinct pathways (men upregulated LXR/RXR whereas women downregulated LXR/RXR) to arrive at a similar pathophysiological end point (i.e., heart failure). Our data revealed the sex-dependent mechanisms whereby mice and humans with MI progress to heart failure (Fig. 10). To our knowledge, this is the first report to dissect the distinct neutrophil signaling pathways stimulated after MI to activate progression to heart failure.
The major strengths of this study include the use of both mice and human data to provide a cross-translational perspective, the evaluation of human MI samples before heart failure was diagnosed, and the use of a convergence approach using both genomics and proteomics in plasma, LV tissue, and isolated neutrophils to provide a comprehensive mechanistic evaluation. Our results highlight the strong agreement at gene and protein levels for the pathways most involved in the post-MI progression to heart failure (Online Table 5).
Although sex differences in cardiovascular disease are caused in part by environmental or social differences such as occupational hazards, habits, and social stresses, we focused here on biological factors that regulate cardiac wound healing. This study used a population-based cohort of middle aged and older adults of African Ancestry in a single community, which strengthened the translational impact of our findings. As sample sizes could not be controlled given the retrospective study design, the n for the male heart failure group was small and glycoproteomics was measured at a single time point, which varied in its temporal relation between MI and onset of heart failure. Of note, the incidence of heart failure was 25%, which is similar to what larger clinical studies have shown [24, 29, 68, 79]. Comparison of our findings with a larger prospective cohort and including additional ethnicities/races, regions/countries, and ages is warranted.
Sex differences in inflammation have been shown in animal models and humans. Men have elevated leukocyte-mediated inflammation in atherosclerotic plaques, consistent with the pro-inflammation status seen in the post-MI LV [20]. In contrast, young women have a more temperate inflammatory response. Our data revealed that neutrophils isolated from males remove necrotic tissue through CD36-dependent degranulation of MMP-9. Females, on the other hand, removed necrotic tissue by secreting proteins, in addition to cellular mechanisms including phagocytosis. Neutrophils in young females were more efficient at removing necrotic tissue than neutrophils isolated from young males. Reduced neutrophil numbers observed in female hearts after MI also protects from collateral damage incurred by neutrophil-derived mediators. While both neutrophils and macrophages use LXR/RXR signaling and are equally responsible for adverse post-MI remodeling [58, 67, 78], the neutrophil difference was prominent. Future studies that investigate the role of other immune cells, including macrophages and T and B lymphocytes, are needed to fully understand all sex differences in cardiovascular disease pathology. In a mouse model of sepsis, females exhibited dampened inflammation and less tissue injury due to heightened leukocyte sensitivity to infectious and injurious stimuli compared to male mice [71]. In our study, the sex difference in inflammation diminished with age, as female mice (11–36 months-old) and women both showed reduced LXR/RXR pathway signaling.
LXR/RXR signaling was a top ranked canonical pathway associated with post-MI development of heart failure in our human sample set, highlighting the significance of this pathway. LXR/RXR signaling regulates inflammation, cholesterol homeostasis, and lipid and glucose metabolism [8]. After ischemic injury, the LXR/RXR pathway decreases cardiomyocyte hypertrophy and promotes cell survival, modulates myocardial metabolism, promotes angiogenesis, and attenuates fibrosis [8]. Estrogen attenuates and antagonizes the expression of LXR and its transcriptional activity [11, 25, 44]. Interestingly, our data showed that aged females had a loss of LXR/RXR activation, demonstrating in neutrophils the effects that we observed are most likely independent of hormonal influences and more likely due to X chromosome actions.
Apo F indirectly regulates CD36 by binding to high-density lipoproteins and is a known activator of the LXR/RXR pathway [43]. Our study indicated Apo F regulated neutrophil mediated-tissue clearance in males by increasing secretion of MMP-9. Interestingly, with CD36i, MMP-9 secretion was attenuated in males, indicating neutrophil secretion of MMP-9 is independent of NF-κB activation. Female neutrophils, however, regulated tissue clearance independent of CD36 and MMP-9. Our data indicate females remove necrotic tissue through secretion of both NO and ROS as well as through phagocytosis. In turn, this would result in better removal of necrotic tissue without excessive damage to the myocardium.
Our data reveal different roles played by PPARγ in women versus men. A similar paradigm occurs in T cells, where PPARγ inhibits activation in female, but not male cells [61]. Neutrophils from females did not rely on PPARγ and instead activated AMPK through TSP activation of CD36. Our understanding of the cross-talk from PPARγ to AMPK remains controversial, as AMPK activation is either a PPAR-γ-dependent or independent process depending on the study [57]. AMPK also inhibits PPARγ activation in other disease models [73] representative of bi-directional cross-talk, which would explain why in vitro Apo F stimulation did not activate PPARγ in females but still triggered a physiological response (e.g., tissue clearance).
After MI, NF-κB was activated in males to stimulate pro-inflammatory N1 neutrophils to release MMP-9. During heart failure development, Apo F increased in an attempt to protect the myocardium by activating LXR/RXR signaling through CD36 and PPARγ activation. When CD36 was inhibited or cleaved by MMP-9, [19] PPARγ could no longer inhibit NF-κB activation, leading to increased N1 polarization and decreased N2 polarization. In vivo, young females activated the NF-κB pathway to a lesser extent and relied on TSP-1 activation of the AMPK pathway. With age, females lost their ability to activate the LXR/RXR pathway, resulting in increased NF-κB activation despite elevated Apo F levels. A loss of LXR/RXR signaling in older female mice may, therefore, be detrimental by preventing a post-MI inflammation resolution response, resulting in prolonged exposure to pro-inflammatory cytokines such as IL6. Our study provides the first evidence that the myocardium of older men and women remodel after MI using divergent pathway activation to arrive at a common pathophysiological end point.
The comparison between human and mice responses to MI shows that while there are distinct species attributes, there exists significant commonality in the post-MI response (Online Table 6). When gene expression was compared across human and mouse models of burn, sepsis, and trauma, researchers found significant species overlap among conditions and pathways [75]. This was especially true for genes involved in the innate immune response, cytokine signaling in immune system, and lymphocyte differentiation. Our findings, therefore, indicate that cross-species comparisons can help to identify salient pathways. The alignment between gene and protein and between plasma and LV infarct tissue was also well preserved, signifying that combining approaches can provide a powerful tool to increase the signal to noise ratio and hone in on the most informative signaling pathways.
One strength to our study is that we used the non-reperfused MI mouse model in both young and old animals, which provides robust remodeling endpoints (i.e., ventricular rupture and mortality) [39, 59]. The majority of MI patients who present to the emergency department undergo reperfusion and are optimally treated with aspirin, angiotensin converting enzyme inhibitors, beta blockers, and statins and are not reflected by the permanent occlusion model. Our model represents the 40% of MI patients who either do not receive timely reperfusion due to late presentation or confounding issues or go on to develop heart failure. Although rupture rates for human patient populations are difficult to standardize and compare across studies, clinical evidence supports the concept that older female patients are more likely to rupture than males [30]. We evaluated LV tissue and plasma in mice, while in the human cohort only plasma samples were evaluated. Thus, all healing patterns observed in the mouse model were interpreted with caution when comparing to the population dataset.
In conclusion, inflammation resolution was a critical component of MI remodeling that occurred under sex-dependent mechanisms. Our results highlight the need to not only understand mechanisms that dampen but also mechanisms that turn off inflammation [27, 33, 35, 36].
References
Abdelrahman M, Sivarajah A, Thiemermann C (2005) Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock. Cardiovas Res 65:772–781. https://doi.org/10.1016/j.cardiores.2004.12.008
Ahnve S (1985) QT interval prolongation in acute myocardial infarction. Eur Heart J 6(Suppl D):85–95. https://doi.org/10.1093/eurheartj/6.suppl_d.85
Akira S, Kishimoto T (1992) IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 127:25–50. https://doi.org/10.1111/j.1600-065X.1992.tb01407.x
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Statistics C, Stroke Statistics S (2017) Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 135:146–603. https://doi.org/10.1161/CIR.0000000000000485
Brooks HL, Lindsey ML (2018) Guidelines for authors and reviewers on antibody use in physiology studies. Am J Physiol Heart Circ Physiol. https://doi.org/10.1152/ajpheart.00512.2017
Brundert M, Heeren J, Merkel M, Carambia A, Herkel J, Groitl P, Dobner T, Ramakrishnan R, Moore KJ, Rinninger F (2011) Scavenger receptor CD36 mediates uptake of high density lipoproteins in mice and by cultured cells. J Lipid Res 52:745–758. https://doi.org/10.1194/jlr.M011981
Bucholz EM, Butala NM, Rathore SS, Dreyer RP, Lansky AJ, Krumholz HM (2014) Sex differences in long-term mortality after myocardial infarction: a systematic review. Circulation 130:757–767. https://doi.org/10.1161/CIRCULATIONAHA.114.009480
Cannon MV, van Gilst WH, de Boer RA (2016) Emerging role of liver X receptors in cardiac pathophysiology and heart failure. Basic Res Cardiol 111:3. https://doi.org/10.1007/s00395-015-0520-7
Cavasin MA, Tao Z, Menon S, Yang XP (2004) Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice. Life Sci 75:2181–2192. https://doi.org/10.1016/j.lfs.2004.04.024
Chiao YA, Dai Q, Zhang J, Lin J, Lopez EF, Ahuja SS, Chou YM, Lindsey ML, Jin YF (2011) Multi-analyte profiling reveals matrix metalloproteinase-9 and monocyte chemotactic protein-1 as plasma biomarkers of cardiac aging. Circ Cardiovasc Genet 4:455–462. https://doi.org/10.1161/CIRCGENETICS.111.959981
D’Eon TM, Souza SC, Aronovitz M, Obin MS, Fried SK, Greenberg AS (2005) Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem 280:35983–35991. https://doi.org/10.1074/jbc.M507339200
Damjanov N, Kauffman RS, Spencer-Green GT (2009) Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies. Arthritis Rheum 60:1232–1241. https://doi.org/10.1002/art.24485
de Castro Bras LE, Cates CA, Deleon-Pennell KY, Ma Y, Iyer RP, Halade GV, Yabluchanskiy A, Fields GB, Weintraub ST, Lindsey ML (2014) Citrate synthase is a novel in vivo matrix metalloproteinase-9 substrate that regulates mitochondrial function in the postmyocardial infarction left ventricle. Antioxid Redox Signal 21:1974–1985. https://doi.org/10.1089/ars.2013.5411
de Castro Bras LE, Ramirez TA, DeLeon-Pennell KY, Chiao YA, Ma Y, Dai Q, Halade GV, Hakala K, Weintraub ST, Lindsey ML (2013) Texas 3-step decellularization protocol: looking at the cardiac extracellular matrix. J Proteom 86:43–52. https://doi.org/10.1016/j.jprot.2013.05.004
DeCoux A, Tian Y, DeLeon-Pennell KY, Nguyen NT, de Castro Bras LE, Flynn ER, Cannon PL, Griswold ME, Jin YF, Puskarich MA, Jones AE, Lindsey ML (2015) Plasma glycoproteomics reveals sepsis outcomes linked to distinct proteins in common pathways. Crit Care Med 43:2049–2058. https://doi.org/10.1097/ccm.0000000000001134
DeLeon-Pennell KY, Iyer RP, Ero OK, Cates CA, Flynn ER, Cannon PL, Jung M, Shannon D, Garrett MR, Buchanan W, Hall ME, Ma Y, Lindsey ML (2017) Periodontal-induced chronic inflammation triggers macrophage secretion of Ccl12 to inhibit fibroblast-mediated cardiac wound healing. JCI Insight 2:e94207. https://doi.org/10.1172/jci.insight.94207
DeLeon-Pennell KY, Iyer RP, Ma Y, Yabluchanskiy A, Zamilpa R, Chiao YA, Cannon P, Cates C, Flynn ER, Halade GV, de Castro Bras LE, Lindsey ML (2018) The mouse heart attack research tool (mHART) 10 Database. Am J Physiol Heart Circ Physiol. https://doi.org/10.1152/ajpheart.00172.2018
DeLeon-Pennell KY, Meschiari CA, Jung M, Lindsey ML (2017) Matrix Metalloproteinases in Myocardial Infarction and Heart Failure. Prog Mol Biol Transl Sci 147:75–100. https://doi.org/10.1016/bs.pmbts.2017.02.001
DeLeon-Pennell KY, Tian Y, Zhang B, Cates CA, Iyer RP, Cannon P, Shah P, Aiyetan P, Halade GV, Ma Y, Flynn E, Zhang Z, Jin YF, Zhang H, Lindsey ML (2016) CD36 is a matrix metalloproteinase-9 substrate that stimulates neutrophil apoptosis and removal during cardiac remodeling. Circ Cardiovasc Genet 9:14–25. https://doi.org/10.1161/CIRCGENETICS.115.001249
Fairweather D (2014) Sex differences in inflammation during atherosclerosis. Clin Med Insights Cardiol 8:49–59. https://doi.org/10.4137/CMC.S17068
Feldmann R, Fischer C, Kodelja V, Behrens S, Haas S, Vingron M, Timmermann B, Geikowski A, Sauer S (2013) Genome-wide analysis of LXRalpha activation reveals new transcriptional networks in human atherosclerotic foam cells. Nucleic Acids Res 41:3518–3531. https://doi.org/10.1093/nar/gkt034
Fenton RR, Molesworth-Kenyon S, Oakes JE, Lausch RN (2002) Linkage of IL-6 with neutrophil chemoattractant expression in virus-induced ocular inflammation. Invest Ophthalmol Vis Sci 43:737–743
Finch CE, Felicio LS, Mobbs CV, Nelson JF (1984) Ovarian and steroidal influences on neuroendocrine aging processes in female rodents. Endocr Rev 5:467–497. https://doi.org/10.1210/edrv-5-4-467
Gho J, Schmidt AF, Pasea L, Koudstaal S, Pujades-Rodriguez M, Denaxas S, Shah AD, Patel RS, Gale CP, Hoes AW, Cleland JG, Hemingway H, Asselbergs FW (2018) An electronic health records cohort study on heart failure following myocardial infarction in England: incidence and predictors. BMJ Open 8:e018331. https://doi.org/10.1136/bmjopen-2017-018331
Gong H, Guo P, Zhai Y, Zhou J, Uppal H, Jarzynka MJ, Song WC, Cheng SY, Xie W (2007) Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. Mol Endocrinol 21:1781–1790. https://doi.org/10.1210/me.2007-0187
Gosden RG, Laing SC, Felicio LS, Nelson JF, Finch CE (1983) Imminent oocyte exhaustion and reduced follicular recruitment mark the transition to acyclicity in aging C57BL/6 J mice. Biol Reprod 28:255–260. https://doi.org/10.1095/biolreprod28.2.255
Halade GV, Kain V, Ingle KA, Prabhu SD (2017) Interaction of 12/15-lipoxygenase with fatty acids alters the leukocyte kinetics leading to improved postmyocardial infarction healing. Am J Physiol Heart Circ Physiol 313:H89–H102. https://doi.org/10.1152/ajpheart.00040.2017
Harbord M, Novelli M, Canas B, Power D, Davis C, Godovac-Zimmermann J, Roes J, Segal AW (2002) Ym1 is a neutrophil granule protein that crystallizes in p47phox-deficient mice. J Biol Chem 277:5468–5475. https://doi.org/10.1074/jbc.M110635200
Hernandez AF, Velazquez EJ, Solomon SD, Kilaru R, Diaz R, O’Connor CM, Ertl G, Maggioni AP, Rouleau JL, van Gilst W, Pfeffer MA, Califf RM, Registry V (2005) Left ventricular assessment in myocardial infarction: the VALIANT registry. Arch Intern Med 165:2162–2169. https://doi.org/10.1001/archinte.165.18.2162
Hutchins KD, Skurnick J, Lavenhar M, Natarajan GA (2002) Cardiac rupture in acute myocardial infarction: a reassessment. Am J Forensic Med Pathol 23:78–82
Iyer RP, de Castro Bras LE, Patterson NL, Bhowmick M, Flynn ER, Asher M, Cannon PL, Deleon-Pennell KY, Fields GB, Lindsey ML (2016) Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution. J Mol Cell Cardiol 100:109–117. https://doi.org/10.1016/j.yjmcc.2016.10.005
Iyer RP, Patterson NL, Zouein FA, Ma Y, Dive V, de Castro Bras LE, Lindsey ML (2015) Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution. Int J Cardiol 185:198–208. https://doi.org/10.1016/j.ijcard.2015.03.054
Jadapalli JK, Halade GV (2018) Unified nexus of macrophages and maresins in cardiac reparative mechanisms. FASEB J. https://doi.org/10.1096/fj.201800254r
Jensen LE, Whitehead AS (1998) Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J 334(Pt 3):489–503. https://doi.org/10.1042/bj3340489
Kain V, Ingle KA, Kabarowski J, Barnes S, Limdi NA, Prabhu SD, Halade GV (2018) Genetic deletion of 12/15 lipoxygenase promotes effective resolution of inflammation following myocardial infarction. J Mol Cell Cardiol 118:70–80. https://doi.org/10.1016/j.yjmcc.2018.03.004
Kain V, Liu F, Kozlovskaya V, Ingle KA, Bolisetty S, Agarwal A, Khedkar S, Prabhu SD, Kharlampieva E, Halade GV (2017) Resolution agonist 15-epi-Lipoxin A4 programs early activation of resolving phase in post-myocardial infarction healing. Sci Rep 7:9999. https://doi.org/10.1038/s41598-017-10441-8
Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 8:e1000412. https://doi.org/10.1371/journal.pbio.1000412
Kim I, He YY (2013) Targeting the AMP-activated protein kinase for cancer prevention and therapy. Front Oncol 3:175. https://doi.org/10.3389/fonc.2013.00175
Klocke R, Tian W, Kuhlmann MT, Nikol S (2007) Surgical animal models of heart failure related to coronary heart disease. Cardiovasc Res 74:29–38. https://doi.org/10.1016/j.cardiores.2006.11.026
Kobara M, Noda K, Kitamura M, Okamoto A, Shiraishi T, Toba H, Matsubara H, Nakata T (2010) Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice. Cardiovasc Res 87:424–430. https://doi.org/10.1093/cvr/cvq078
Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Kohler G (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339–342. https://doi.org/10.1038/368339a0
Kopf M, Herren S, Wiles MV, Pepys MB, Kosco-Vilbois MH (1998) Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component. J Exp Med 188:1895–1906. https://doi.org/10.1084/jem.188.10.1895
Koren E, McConathy WJ, Alaupovic P (1982) Isolation and characterization of simple and complex lipoproteins containing apolipoprotein F from human plasma. Biochemistry 21:5347–5351. https://doi.org/10.1021/bi00264a035
Krycer JR, Brown AJ (2011) Cross-talk between the androgen receptor and the liver X receptor: implications for cholesterol homeostasis. J Biol Chem 286:20637–20647. https://doi.org/10.1074/jbc.M111.227082
Lagor WR, Brown RJ, Toh SA, Millar JS, Fuki IV, de la Llera-Moya M, Yuen T, Rothblat G, Billheimer JT, Rader DJ (2009) Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivo. Arterioscler Thromb Vasc Biol 29:40–46. https://doi.org/10.1161/ATVBAHA.108.177105
Li HY, Su YY, Zhang YF, Liu ZQ, Hua BJ (2016) Involvement of peroxisome proliferator activated receptor-gamma in the anti-inflammatory effects of atorvastatin in oxygen-glucose deprivation/reperfusion-stimulated RAW264.7 murine macrophages. Mol Med Rep 14:4055–4062. https://doi.org/10.3892/mmr.2016.5742
Lin JF, Hsu SY, Wu S, Teng MS, Chou HH, Cheng ST, Wu TY, Ko YL (2015) QT interval independently predicts mortality and heart failure in patients with ST-elevation myocardial infarction. Int J Med Sci 12:968–973. https://doi.org/10.7150/ijms.13121
Lindsey ML (2018) Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling. Nat Rev Cardiol. https://doi.org/10.1038/s41569-018-0022-z
Lindsey ML, Bolli R, Canty JM Jr, Du XJ, Frangogiannis NG, Frantz S, Gourdie RG, Holmes JW, Jones SP, Kloner RA, Lefer DJ, Liao R, Murphy E, Ping P, Przyklenk K, Recchia FA, Schwartz Longacre L, Ripplinger CM, Van Eyk JE, Heusch G (2018) Guidelines for experimental models of myocardial ischemia and infarction. Am J Physiol Heart Circ Physiol 314:H812–H838. https://doi.org/10.1152/ajpheart.00335.2017
Lindsey ML, Escobar GP, Mukherjee R, Goshorn DK, Sheats NJ, Bruce JA, Mains IM, Hendrick JK, Hewett KW, Gourdie RG, Matrisian LM, Spinale FG (2006) Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation 113:2919–2928. https://doi.org/10.1161/CIRCULATIONAHA.106.612960
Lindsey ML, Kassiri Z, Virag JAI, de Castro Bras LE, Scherrer-Crosbie M (2018) Guidelines for measuring cardiac physiology in mice. Am J Physiol Heart Circ Physiol. https://doi.org/10.1152/ajpheart.00339.2017
Lopez EF, Kabarowski JH, Ingle KA, Kain V, Barnes S, Crossman DK, Lindsey ML, Halade GV (2015) Obesity superimposed on aging magnifies inflammation and delays the resolving response after myocardial infarction. Am J Physiol Heart Circ Physiol 308:H269–H280. https://doi.org/10.1152/ajpheart.00604.2014
Ma Y, Chiao YA, Zhang J, Manicone AM, Jin YF, Lindsey ML (2012) Matrix metalloproteinase-28 deletion amplifies inflammatory and extracellular matrix responses to cardiac aging. Microsc Microanal 18:81–90. https://doi.org/10.1017/S1431927611012220
Ma Y, Yabluchanskiy A, Iyer RP, Cannon PL, Flynn ER, Jung M, Henry J, Cates CA, Deleon-Pennell KY, Lindsey ML (2016) Temporal neutrophil polarization following myocardial infarction. Cardiovasc Res 110:51–61. https://doi.org/10.1093/cvr/cvw024
Mak PA, Laffitte BA, Desrumaux C, Joseph SB, Curtiss LK, Mangelsdorf DJ, Tontonoz P, Edwards PA (2002) Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors alpha and beta. J Biol Chem 277:31900–31908. https://doi.org/10.1074/jbc.M202993200
Mobbs CV, Gee DM, Finch CE (1984) Reproductive senescence in female C57BL/6 J mice: ovarian impairments and neuroendocrine impairments that are partially reversible and delayable by ovariectomy. Endocrinology 115:1653–1662. https://doi.org/10.1210/endo-115-5-1653
Morrison A, Li J (2011) PPAR-gamma and AMPK–advantageous targets for myocardial ischemia/reperfusion therapy. Biochem Pharmacol 82:195–200. https://doi.org/10.1016/j.bcp.2011.04.004
Mouton AJ, DeLeon-Pennell KY, Rivera Gonzalez OJ, Flynn ER, Freeman TC, Saucerman JJ, Garrett MR, Ma Y, Harmancey R, Lindsey ML (2018) Mapping macrophage polarization over the myocardial infarction time continuum. Basic Res Cardiol 113:26. https://doi.org/10.1007/s00395-018-0686-x
Muthuramu I, Lox M, Jacobs F, De Geest B (2014) Permanent ligation of the left anterior descending coronary artery in mice: a model of post-myocardial infarction remodelling and heart failure. J Vis Exp. https://doi.org/10.3791/52206
Pancholy SB, Shantha GP, Patel T, Cheskin LJ (2014) Sex differences in short-term and long-term all-cause mortality among patients with ST-segment elevation myocardial infarction treated by primary percutaneous intervention: a meta-analysis. JAMA Intern Med 174:1822–1830. https://doi.org/10.1001/jamainternmed.2014.4762
Park HJ, Kim DH, Choi JY, Kim WJ, Kim JY, Senejani AG, Hwang SS, Kim LK, Tobiasova Z, Lee GR, Craft J, Bothwell AL, Choi JM (2014) PPARgamma negatively regulates T cell activation to prevent follicular helper T cells and germinal center formation. PLoS ONE 9:e99127. https://doi.org/10.1371/journal.pone.0099127
Pechlaner R, Tsimikas S, Yin X, Willeit P, Baig F, Santer P, Oberhollenzer F, Egger G, Witztum JL, Alexander VJ, Willeit J, Kiechl S, Mayr M (2017) Very-low-density lipoprotein-associated apolipoproteins predict cardiovascular events and are lowered by inhibition of APOC-III. J Am Coll Cardiol 69:789–800. https://doi.org/10.1016/j.jacc.2016.11.065
Pedrinaci S, Ruiz-Cabello F, Gomez O, Collado A, Garrido F (1990) Protein kinase C-mediated regulation of the expression of CD14 and CD11/CD18 in U937 cells. Int J Cancer 45:294–298. https://doi.org/10.1002/ijc.2910450215
Penas F, Mirkin GA, Vera M, Cevey A, Gonzalez CD, Gomez MI, Sales ME, Goren NB (2015) Treatment in vitro with PPARalpha and PPARgamma ligands drives M1-to-M2 polarization of macrophages from T. cruzi-infected mice. Biochim Biophys Acta 1852:893–904. https://doi.org/10.1016/j.bbadis.2014.12.019
Peng Y, Liu H, Liu F, Wang H, Liu Y, Duan S (2005) Inhibitory effect of PPAR-gamma activator on IL-6 and mPGES protein expression in PBMC induced by homocysteine. Hemodial Int 9(Suppl 1):S15–S20. https://doi.org/10.1111/j.1542-4758.2005.01165.x
Rathod KS, Kapil V, Velmurugan S, Khambata RS, Siddique U, Khan S, Van Eijl S, Gee LC, Bansal J, Pitrola K, Shaw C, D’Acquisto F, Colas RA, Marelli-Berg F, Dalli J, Ahluwalia A (2017) Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans. J Clin Invest 127:169–182. https://doi.org/10.1172/JCI89429
Rienks M, Carai P, Bitsch N, Schellings M, Vanhaverbeke M, Verjans J, Cuijpers I, Heymans S, Papageorgiou A (2017) Sema3A promotes the resolution of cardiac inflammation after myocardial infarction. Basic Res Cardiol 112:42. https://doi.org/10.1007/s00395-017-0630-5
Roger VL (2013) Epidemiology of heart failure. Circ Res 113:646–659. https://doi.org/10.1161/CIRCRESAHA.113.300268
Salt IP, Palmer TM (2012) Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation. Expert Opin Investig Drugs 21:1155–1167. https://doi.org/10.1517/13543784.2012.696609
Sawa Y, Ichikawa H, Kagisaki K, Ohata T, Matsuda H (1998) Interleukin-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium. J Thorac Cardiovasc Surg 116:511–517. https://doi.org/10.1016/S0022-5223(98)70018-2
Scotland RS, Stables MJ, Madalli S, Watson P, Gilroy DW (2011) Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female mice. Blood 118:5918–5927. https://doi.org/10.1182/blood-2011-03-340281
Song MG, Ryoo IG, Choi HY, Choi BH, Kim ST, Heo TH, Lee JY, Park PH, Kwak MK (2015) NRF2 signaling negatively regulates phorbol-12-myristate-13-acetate (PMA)-induced differentiation of human monocytic U937 cells into pro-inflammatory macrophages. PLoS ONE 10:e0134235. https://doi.org/10.1371/journal.pone.0134235
Sozio MS, Lu C, Zeng Y, Liangpunsakul S, Crabb DW (2011) Activated AMPK inhibits PPAR-{alpha} and PPAR-{gamma} transcriptional activity in hepatoma cells. Am J Physiol Gastrointest Liver Physiol 301:G739–G747. https://doi.org/10.1152/ajpgi.00432.2010
Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, Flanigan A, Murthy S, Lazar MA, Wu GD (1999) A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest 104:383–389. https://doi.org/10.1172/JCI7145
Takao K, Miyakawa T (2015) Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc Natl Acad Sci USA 112:1167–1172. https://doi.org/10.1073/pnas.1401965111
Tian Y, Kelly-Spratt KS, Kemp CJ, Zhang H (2010) Mapping tissue-specific expression of extracellular proteins using systematic glycoproteomic analysis of different mouse tissues. J Proteome Res 9:5837–5847. https://doi.org/10.1021/pr1006075
Tian Y, Koganti T, Yao Z, Cannon P, Shah P, Pietrovito L, Modesti A, Aiyetan P, DeLeon-Pennell K, Ma Y, Halade GV, Hicks C, Zhang H, Lindsey ML (2014) Cardiac extracellular proteome profiling and membrane topology analysis using glycoproteomics. Proteom Clin Appl 8:595–602. https://doi.org/10.1002/prca.201400009
Tomczyk M, Kraszewska I, Szade K, Bukowska-Strakova K, Meloni M, Jozkowicz A, Dulak J, Jazwa A (2017) Splenic Ly6C(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice. Basic Res Cardiol 112:39. https://doi.org/10.1007/s00395-017-0629-y
Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D’Agostino RB, Levy D, Kannel WB, Vasan RS (2008) Long-term trends in the incidence of heart failure after myocardial infarction. Circulation 118:2057–2062. https://doi.org/10.1161/CIRCULATIONAHA.108.784215
Vizcaino JA, Csordas A, Del-Toro N, Dianes JA, Griss J, Lavidas I, Mayer G, Perez-Riverol Y, Reisinger F, Ternent T, Xu QW, Wang R, Hermjakob H (2016) 2016 update of the PRIDE database and its related tools. Nucleic Acids Res 44:11033. https://doi.org/10.1093/nar/gkw880
Voorhees AP, DeLeon-Pennell KY, Ma Y, Halade GV, Yabluchanskiy A, Iyer RP, Flynn E, Cates CA, Lindsey ML, Han HC (2015) Building a better infarct: modulation of collagen cross-linking to increase infarct stiffness and reduce left ventricular dilation post-myocardial infarction. J Mol Cell Cardiol 85:229–239. https://doi.org/10.1016/j.yjmcc.2015.06.006
Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411–422. https://doi.org/10.1016/S0092-8674(00)81169-1
Wilson JG, Rotimi CN, Ekunwe L, Royal CD, Crump ME, Wyatt SB, Steffes MW, Adeyemo A, Zhou J, Taylor HA Jr, Jaquish C (2005) Study design for genetic analysis in the Jackson Heart Study. Ethn Dis 15:S6–S30
World Medical A (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310:2191–2194. https://doi.org/10.1001/jama.2013.281053
Xia J, Sinelnikov IV, Han B, Wishart DS (2015) MetaboAnalyst 3.0–making metabolomics more meaningful. Nucleic Acids Res 43:W251–W257. https://doi.org/10.1093/nar/gkv380
Yabluchanskiy A, Ma Y, DeLeon-Pennell KY, Altara R, Halade GV, Voorhees AP, Nguyen NT, Jin YF, Winniford MD, Hall ME, Han HC, Lindsey ML (2016) Myocardial infarction superimposed on aging: MMP-9 deletion promotes M2 macrophage polarization. J Gerontol A Biol Sci Med Sci 71:475–483. https://doi.org/10.1093/gerona/glv034
Zamilpa R, Kanakia R, Jt Cigarroa, Dai Q, Escobar GP, Martinez H, Jimenez F, Ahuja SS, Lindsey ML (2011) CC chemokine receptor 5 deletion impairs macrophage activation and induces adverse remodeling following myocardial infarction. Am J Physiol Heart Circ Physiol 300:H1418–H1426. https://doi.org/10.1152/ajpheart.01002.2010
Zamilpa R, Lopez EF, Chiao YA, Dai Q, Escobar GP, Hakala K, Weintraub ST, Lindsey ML (2010) Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction. Proteomics 10:2214–2223. https://doi.org/10.1002/pmic.200900587
Acknowledgements
The authors also wish to thank the staff and participants of the Jackson Heart Study. The Jackson Heart Study is supported and conducted in collaboration with Jackson State University (HHSN268201300049C and HHSN268201300050C), Tougaloo College (HHSN268201300048C), and the University of Mississippi Medical Center (HHSN268201300046C and HHSN268201300047C) contracts from the National Heart, Lung, and Blood Institute and the National Institute for Minority Health and Health Disparities. This work was also supported by the American Heart Association 15SDG22930009 to YM and 18POST34000039 to AJM and the National Institute of Health T32HL105324 to AJM and OKE and HL075360, HL129823, and GM114833 to MLL, and from the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development Award 5I01BX000505 to MLL and IK2BX003922 to KYD-P, and by HL051971, GM104357, and GM115428. The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the National Institutes of Health; the U.S. Department of Health and Human Services; the American Heart Association; or the U.S. Department of Veterans Affairs.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
DeLeon-Pennell, K.Y., Mouton, A.J., Ero, O.K. et al. LXR/RXR signaling and neutrophil phenotype following myocardial infarction classify sex differences in remodeling. Basic Res Cardiol 113, 40 (2018). https://doi.org/10.1007/s00395-018-0699-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00395-018-0699-5